Your browser doesn't support javascript.
loading
Ischemic Cholangiopathy Postdonation After Circulatory Death Liver Transplantation: Donor Hepatectomy Time Matters.
Goussous, Naeem; Alvarez-Casas, Josue; Dawany, Noor; Xie, Wen; Malik, Saad; Gray, Stephen H; Barth, Rolf N; LaMattina, John C.
Affiliation
  • Goussous N; Division of Transplantation, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD.
  • Alvarez-Casas J; Division of Transplantation, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD.
  • Dawany N; Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA.
  • Xie W; Division of Transplantation, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD.
  • Malik S; Division of Transplantation, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD.
  • Gray SH; Division of Transplantation, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD.
  • Barth RN; Division of Transplantation, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD.
  • LaMattina JC; Division of Transplantation, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD.
Transplant Direct ; 8(1): e1277, 2022 Jan.
Article in En | MEDLINE | ID: mdl-34966844
ABSTRACT

BACKGROUND:

Outcomes of liver transplantation (LT) from donation after circulatory death (DCD) have been improving; however, ischemic cholangiopathy (IC) continues to be a problem. In 2014, measures to minimize donor hepatectomy time (DHT) and cold ischemic time (CIT) have been adopted to improve DCD LT outcomes.

METHODS:

Retrospective review of all patients who underwent DCD LT between 2005 and 2017 was performed. We compared outcomes of patients who were transplanted before 2014 (historic group) with those who were transplanted between 2014 and 2017 (modern group).

RESULTS:

We identified 112 patients; 44 were in the historic group and 68 in the modern group. Donors in the historic group were younger (26.5 versus 33, P = 0.007) and had a lower body mass index (26.2 versus 28.2, P = 0.007). DHT (min) and CIT (h) were significantly longer in the historic group (21.5 versus 14, P < 0.001 and 5.3 versus 4.2, P < 0.001, respectively). Fourteen patients (12.5%) developed IC, with a significantly higher incidence in the historic group (23.3% versus 6.1%, P = 0.02). There was no difference in graft and patient survival between both groups.

CONCLUSION:

In appropriately selected recipients, minimization of DHT and CIT may decrease the incidence of IC. These changes can potentially expand the DCD donor pool.

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Transplant Direct Year: 2022 Document type: Article Affiliation country: Moldova

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Transplant Direct Year: 2022 Document type: Article Affiliation country: Moldova
...